Dr. Huynh Cao, MD

Dr. Cao practices at Riverside Medical Center in Riverside, California, part of Kaiser Permanente.

Dr. Cao's NPI, 1720238249, was assigned on September 19, 2008. Dr. Cao graduated from David Geffen School of Medicine at UCLA in 2008. Dr. Cao's California license number on file is A118581.

Dr. Cao's primary practice is Riverside Medical Center, at 10800 Magnolia Avenue, Riverside, CA 92505 in Riverside County. The practice phone is (951) 353-2000.

Dr. Cao's primary practice is Riverside Medical Center in Riverside, California, part of Kaiser Permanente. Dr. Cao is also affiliated with Loma Linda University Medical Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Cao to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cao practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Cao's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Cao is board certified in internal medicine by the American Board of Internal Medicine. Dr. Cao has a license on file in California.

Dmand AI lists chronic anemia, deep vein thrombosis (DVT), ear infection, fluid and electrolyte imbalances, insomnia, purpura and thrombocytopenia and tobacco use among the conditions Dr. Cao treats.

CMS data shows 196 Medicare services from Dr. Cao across 2 procedure codes in 2024, all of them office visits, for 119 Medicare patients. Medicare paid $9,911 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 119 Medicare patients who saw Dr. Cao in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high blood pressure, and 59% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cao's median patient age at 58, with 62% women.

In 2024, Dr. Cao wrote 972 Medicare Part D claims for 197 patients. 81% of them were for generic drugs. CMS names the drug for 693 of them, across 30 drugs with 11 or more claims each, at $773,382 in total drug cost. In 2023, CMS named 837 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Cao for performance year 2024, reported as part of a group. Dr. Cao accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 31 papers to Dr. Cao, published from 2017 to 2025. 2022 was the busiest year, with 8. The most frequent topics are Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols and Leukemia, Myeloid, Acute. Dr. Cao has published most often in Anticancer Res. Dr. Cao's most frequent co-authors are David Baylink, MD, Mark Evan Reeves, MD and Chien-Shing Chen, MD.

Dmand AI links Dr. Cao to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Epstein-Barr Virus Infections and Tumor Virus Infections.

CMS Open Payments shows 57 general payments to Dr. Cao from 16 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 60% of the total. Bristol-Myers Squibb Company paid the most, $2,575.

Dr. Cao graduated from David Geffen School of Medicine at UCLA in 2008. Dr. Cao is a member of SHM.

Dr. Cao is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.